Impact analysis of signals detected from spontaneous adverse drug reaction reporting data

被引:29
|
作者
Waller, P
Heeley, E
Moseley, J
机构
[1] Patrick Waller Ltd, Consultancy Pharmacovigilance Pharmacoepidemiol, Southampton SO30 2NY, Hants, England
[2] Med & Healthcare Prod Regulatory Agcy, Post Licensing Div, London, England
[3] Med & Healthcare Prod Regulatory Agcy, Pharmacoepidemiol Res Team, London, England
关键词
D O I
10.2165/00002018-200528100-00002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This paper describes a new method of prioritising signals of potential adverse drug reactions (ADRs) detected from spontaneous reports that is called impact analysis. This is an interim step between signal detection and detailed signal evaluation. Using mathematical screening tools, large numbers of signals may now be detected from spontaneous ADR databases. Regulatory authorities need to rapidly prioritise them and focus on those that are most likely to require significant action. Using two scores ranging from one to 100, each with three input variables, signals may be categorised in terms of the strength of evidence (E) and the potential public health impact (P). In a two-by-two figure with empirically derived cut-off points of ten (the logarithmic mean) for each score, signals are placed in one of four categories (A-D) that are ranked according to their priority (A being the highest and D the lowest). A sensitivity analysis is then performed that tests the robustness of the categorisation in relation to each of the six input variables. A computer program has been written to facilitate the process and reduce error. Further work is required to test the feasibility and value of impact analysis in practice.
引用
收藏
页码:843 / 850
页数:8
相关论文
共 50 条
  • [31] Adverse drug reaction reporting
    Kondro, Wayne
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (04) : E192 - E192
  • [32] ADVERSE DRUG REACTION REPORTING
    MANNING, R
    PHARMACY INTERNATIONAL, 1982, 3 (08): : 243 - 243
  • [33] Adverse drug reactions detected by stimulated spontaneous reporting in an internal medicine department in Romania
    Farcas, Andreea
    Sinpetrean, Aura
    Mogosan, Cristina
    Palage, Mariana
    Vostinaru, Oliviu
    Bojita, Marius
    Dumitrascu, Dan
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2010, 21 (05) : 453 - 457
  • [34] SPONTANEOUS ADVERSE REACTION REPORTING IN THE ELDERLY
    TANNER, LA
    BAUM, C
    LANCET, 1988, 2 (8610): : 580 - 580
  • [35] Preventability Analysis of Adverse Drug Reactions Detected by Stimulated Spontaneous Reporting in Two Internal Medicine Departments in Romania
    Farcas, A. M.
    Bucsa, C.
    Sinpetrean, A.
    Mogosan, C.
    Dumitrascu, D.
    Achimas, A.
    Bojita, M.
    DRUG SAFETY, 2011, 34 (10) : 954 - 954
  • [36] Detecting adverse drug events in spontaneous reporting data: A systematic comparison
    Dijkstra, Louis
    Garling, Marco
    Foraita, Ronja
    Pigeot, Iris
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 258 - 258
  • [37] The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database
    Castillon, Genaro
    Salvo, Francesco
    Moride, Yola
    DRUG SAFETY, 2019, 42 (01) : 27 - 34
  • [39] The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database
    Genaro Castillon
    Francesco Salvo
    Yola Moride
    Drug Safety, 2019, 42 : 27 - 34
  • [40] Influence of Regulatory Measures on the Rate of Spontaneous Adverse Drug Reaction Reporting in Italy
    Domenico Motola
    Antonio Vargiu
    Roberto Leone
    Anita Conforti
    Ugo Moretti
    Alberto Vaccheri
    Giampaolo Velo
    Nicola Montanaro
    Drug Safety, 2008, 31 : 609 - 616